tiprankstipranks
Vivos Therapeutics, Inc. (VVOS)
:VVOS
US Market

Vivos Therapeutics (VVOS) Income Statement

Compare
197 Followers

Vivos Therapeutics Income Statement

Last quarter (Q3 2024), Vivos Therapeutics's total revenue was $3.86M, an increase of 16.93% from the same quarter last year. In Q3, Vivos Therapeutics's net income was $-2.62M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 13.80M$ 16.02M$ 16.89M$ 13.07M$ 11.39M
Gross Profit
$ 8.27M$ 10.02M$ 12.60M$ 10.41M$ 8.66M
Operating Expenses
$ 25.57M$ 35.05M$ 32.08M$ 19.12M$ 19.23M
Depreciation and Amortization
$ 621.00K$ 669.00K$ 733.00K$ 717.87K$ 751.23K
EBITDA
$ -16.68M$ -24.36M$ -19.54M$ -11.24M$ -9.87M
Operating Income
$ -17.30M$ -25.03M$ -19.47M$ -8.71M$ -10.58M
Other Income/Expenses
$ 3.71M$ 1.19M$ 94.00K$ -16.88K$ -177.09K
Pretax Income
$ -13.58M$ -23.84M$ -20.29M$ -12.06M$ -10.75M
Net Income
$ -13.58M$ -22.66M$ -20.29M$ -8.82M$ -10.89M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -11.14$ -24.62$ -23.89$ -12.11$ -21.94
Diluted EPS
$ -11.14$ -24.62$ -23.89$ -12.11$ -21.94
Weighted Average Shares Outstanding
1.22M 920.48K 849.32K 728.38K 496.43K
Weighted Average Shares Outstanding (Diluted)
1.22M 920.48K 849.32K 728.38K 496.43K
Currency in USD

Vivos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis